| First Author | Sasaki Y | Year | 2020 |
| Journal | Front Immunol | Volume | 11 |
| Pages | 591713 | PubMed ID | 33178225 |
| Mgi Jnum | J:336797 | Mgi Id | MGI:6729361 |
| Doi | 10.3389/fimmu.2020.591713 | Citation | Sasaki Y, et al. (2020) Distinct Roles of IL-1beta and IL-18 in NLRC4-Induced Autoinflammation. Front Immunol 11:591713 |
| abstractText | The NLRC4 inflammasome assembles in response to detection of bacterial invasion, and NLRC4 activation leads to the production of IL-1beta and IL-18 together with pyroptosis-mediated cell death. Missense activating mutations in NLRC4 cause autoinflammatory disorders whose symptoms are distinctly dependent on the site of mutation and other aspects of the genetic background. To determine the involvement of IL-1beta and IL-18 in the inflammation induced by NLRC4 mutation, we depleted IL-1beta, IL-18, or both cytokines in Nlrc4-transgenic mice in which mutant Nlrc4 is expressed under the MHC class II promoter (Nlrc4-H443P-Tg mice). The deletion of the Il1b or Il18 gene in Nlrc4-H443P-Tg mice reduced the neutrophil numbers in the spleen, and mice with deletion of both genes had an equivalent number of neutrophils compared to wild-type mice. Deletion of Il1b ameliorated but did not eliminate bone marrow hyperplasia, while mice deficient in Il18 showed no bone marrow hyperplasia. In contrast, tail bone deformity remained in the presence of Il18 deficiency, but Il1b deficiency completely abolished bone deformity. The decreased bone density in Nlrc4-H443P-Tg mice was counteracted by Il1b but not Il18 deficiency. Our results demonstrate the distinct effects of IL-1beta and IL-18 on NLRC4-induced inflammation among tissues, which suggests that blockers for each cytokine should be utilized depending on the site of inflammation. |
